Pregnancies with positive non-invasive prenatal testing result for sex chromosome abnormalities in a tertiary hospital in Hong Kong

PL SO; S Lai; PP WONG; KH SIONG; HK LEUNG; WK SIN; Anita SY KAN; HM LUK; Ivan FM LO; KC AU YEUNG; SF WONG

doi:10.12809/hkjgom.22.2.07

Authors

PL SO
S Lai
PP WONG
KH SIONG
HK LEUNG
WK SIN
Anita SY KAN
HM LUK
Ivan FM LO
KC AU YEUNG
SF WONG

DOI:

https://doi.org/10.12809/hkjgom.22.2.07

Keywords:

Genetic testing, Noninvasive prenatal testing, Prenatal diagnosis, Sex chromosome aberrations

Abstract

Objective: To review medical records of pregnant women with positive non-invasive prenatal testing (NIPT) results for sex chromosome abnormalities who attended Tuen Mun hospital between 2015 and 2021. Patient decision after prenatal diagnosis, confirmatory diagnostic testing results, and pregnancy/neonatal outcomes were summarised.

Methods: Medical records of women with abnormal NIPT results for sex chromosome abnormalities who attended Tuen Mun Hospital between January 2015 and December 2021 were retrospectively reviewed.

Results: 56 Chinese women attended our prenatal diagnostic clinic with abnormal NIPT results for sex chromosome abnormalities involving 45,X (n=17), 47,XXY (n=10), 47,XXX (n=6), 47,XYY (n=8), disproportionate level of sex chromosomes (n=9), copy number variants of sex chromosomes (n=3), and suspected maternal sex chromosome imbalance (n=3). 53 had singleton pregnancies and three had dichorionic-diamniotic twin pregnancies. 58.9% had conventional combined Down syndrome screening; 15.2% of them were at high risk for trisomy 21. 33 (58.9%) of the patients opted for invasive diagnostic test: amniocentesis (n=29), chorionic villus sampling (n=3), and chorionic villus sampling followed by amniocentesis (n=1). Confirmatory cytogenetic test results (including postnatal results) were available in 35 cases. The overall positive predictive value of NIPT to detect fetal sex chromosome aneuploidies was 71.4%; the value was 42.9% for detecting 45,X, 100% for detecting 47,XXY, 80% for detecting 47,XXX, and 83.3% for detecting 47,XYY. False positive results were observed in three cases of confined placental mosaicism and three cases of vanishing twin pregnancies. Two women with 47,XXX and one woman with mosaic 45,X/46,XX were also incidentally discovered.
Conclusion: Positive NIPT results for sex chromosome abnormalities can be caused by true fetal sex chromosome abnormalities, confined placental mosaicism/placental mosaicism, vanishing twins, and maternal X chromosome abnormalities. Multidisciplinary management can help prenatal counselling and genetic diagnosis. Follow-up confirmatory cytogenetic analysis prenatally and/or postnatally is useful to characterise the numeric or structural fetal sex chromosome abnormalities and their mosaic patterns, and can maximise the benefits of prenatal genetic screening in obtaining more genetic information to support pregnancy management and clinical care of affected unborn child.

References

Lo YM, Corbetta N, Chamberlain PF, et al. Presence of fetal DNA in maternal plasma and serum. Lancet 1997;350:485-7.

Allyse M, Minear MA, Berson E, et al. Non-invasive prenatal testing: a review of international implementation and challenges. Int J Womens Health 2015;7:113-26.

Gil MM, Accurti V, Santacruz B, Plana MN, Nicolaides KH. Analysis of cell-free DNA in maternal blood in screening for aneuploidies: updated meta-analysis. Ultrasound Obstet Gynecol 2017;50:302-14.

Gil MM, Revello R, Poon LC, Akolekar R, Nicolaides KH. Clinical implementation of routine screening for fetal trisomies in the UK NHS: cell-free DNA test contingent on results from first-trimester combined test. Ultrasound Obstet Gynecol 2016;47:45-52.

Larion S, Warsof SL, Romary L, Mlynarczyk M, Peleg D, Abuhamad AZ. Uptake of noninvasive prenatal testing at a large academic referral center. Am J Obstet Gynecol 2014;211:651.e1-7.

Hui L, Hutchinson B, Poulton A, Halliday J. Population-based impact of noninvasive prenatal screening on screening and diagnostic testing for fetal aneuploidy. Genet Med 2017;19:1338-1345.

Robson SJ, Hui L. National decline in invasive prenatal diagnostic procedures in association with uptake of combined first trimester and cell-free DNA aneuploidy screening. Aust N Z J Obstet Gynaecol 2015;55:507-10.

Warsof SL, Larion S, Abuhamad AZ. Overview of the impact of noninvasive prenatal testing on diagnostic procedures. Prenat Diagn 2015;35:972-9.

Benn P, Borrell A, Chiu RW, et al. Position statement from the Chromosome Abnormality Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenat Diagn 2015;35:725-34.

Mennuti MT, Chandrasekaran S, Khalek N, Dugoff L. Cellfree DNA screening and sex chromosome aneuploidies. Prenat Diagn 2015;35:980-5.

Milunsky JM. Prenatal Diagnosis of Sex Chromosome Abnormalities. In: Milunsky A, Milunsky JM, editors. Genetic Disorders and the Fetus: Diagnosis, Prevention and Treatment. 8th ed. Hoboken, New Jersey: Wiley Blackwell; 2021:499- 546.

Pieters JJ, Kooper AJ, van Kessel AG, Braat DD, Smits AP. Incidental prenatal diagnosis of sex chromosome aneuploidies: health, behavior, and fertility. ISRN Obstet Gynecol 2011;2011:807106.

Lau TK, Chan MK, Salome Lo PS, et al. Non-invasive prenatal screening of fetal sex chromosomal abnormalities: perspective of pregnant women. J Matern Fetal Neonatal Med 2012;25:2616-9.

Marteau TM, Nippert I, Hall S, et al. Decision-making after diagnosis of fetal abnormality. Outcomes of pregnancies diagnosed with Klinefelter syndrome: the possible influence of health professionals. Prenat Diagn 2002;22:562-6.

Kater-Kuipers A, de Beaufort ID, Galjaard RH, Bunnik EM. Rethinking counselling in prenatal screening: An ethical analysis of informed consent in the context of non-invasive prenatal testing (NIPT). Bioethics 2020;34:671-678.

Salomon LJ, Sotiriadis A, Wulff CB, Odibo A, Akolekar R. Risk of miscarriage following amniocentesis or chorionic villus sampling: systematic review of literature and updated meta-analysis. Ultrasound Obstet Gynecol 2019;54:442-451.

Ross JL, Quigley CA, Cao D, et al. Growth hormone plus childhood low-dose estrogen in Turner’s syndrome. N Engl J Med 2011;364:1230-42.

Tartaglia N, Howell S, Davis S, et al. Early neurodevelopmental and medical profile in children with sex chromosome trisomies: Background for the prospective eXtraordinarY babies study to identify early risk factors and targets for intervention. Am J Med Genet C Semin Med Genet 2020;184:428-443.

Samango-Sprouse CA, Tran SL, Lasutschinkow PC, et al. Neurodevelopmental outcome of prenatally diagnosed boys with 47,XXY (Klinefelter syndrome) and the potential influence of early hormonal therapy. Am J Med Genet A 2020;182:1881-1889.

Ramdaney A, Hoskovec J, Harkenrider J, Soto E, Murphy L. Clinical experience with sex chromosome aneuploidies detected by noninvasive prenatal testing (NIPT): Accuracy and patient decision-making. Prenat Diagn 2018;38:841-848.

Liang D, Cram DS, Tan H, et al. Clinical utility of noninvasive prenatal screening for expanded chromosome disease syndromes. Genet Med 2019;21:1998-2006.

Jeon KC, Chen LS, Goodson P. Decision to abort after a prenatal diagnosis of sex chromosome abnormality: a systematic review of the literature. Genet Med 2012;14:27-38.

So PL, Cheng YKY, Cheuk KY, et al. Health professionals’ involvement and information provision in genetic counseling following prenatal diagnosis of sex chromosome aneuploidy in Hong Kong. Int J Gynaecol Obstet 2019;144:314-6.

So PL, Cheng KYY, Cheuk KY, et al. Parental decisions following prenatal diagnosis of sex chromosome aneuploidy in Hong Kong. J Obstet Gynaecol Res 2017;43:1821-9.

Boyd PA, Loane M, Garne E, Khoshnood B, Dolk H; EUROCAT working group. Sex chromosome trisomies in Europe: prevalence, prenatal detection and outcome of pregnancy. Eur J Hum Genet 2011;19:231-4.

Xie X, Tan W, Li F, et al. Diagnostic cytogenetic testing following positive noninvasive prenatal screening results of sex chromosome abnormalities: Report of five cases and systematic review of evidence. Mol Genet Genomic Med 2020;8:e1297.

Engel E. Mosaicism. N Engl J Med 1965;272:34-5.

Malvestiti F, Agrati C, Grimi B, et al. Interpreting mosaicism in chorionic villi: results of a monocentric series of 1001 mosaics in chorionic villi with follow-up amniocentesis. Prenat Diagn 2015;35:1117-27.

Grati FR, Bajaj K, Zanatta V, et al. Implications of fetoplacental mosaicism on cell-free DNA testing for sex chromosome aneuploidies. Prenat Diagn 2017;37:1017-1027.

Cherry AM, Akkari YM, Barr KM, et al. Diagnostic cytogenetic testing following positive noninvasive prenatal screening results: a clinical laboratory practice resource of the American College of Medical Genetics and Genomics (ACMG). Genet Med 2017;19:845-850.

Curnow KJ, Wilkins-Haug L, Ryan A, et al. Detection of triploid, molar, and vanishing twin pregnancies by a singlenucleotide polymorphism-based noninvasive prenatal test. Am J Obstet Gynecol 2015;212:79.e1-9.

Kelley JF, Henning G, Ambrose A, Adelman A. Vanished twins and misdiagnosed sex: a case report with implications in prenatal counseling using noninvasive cell-free DNA screening. J Am Board Fam Med 2016;29:411-3.

Grati FR. Implications of fetoplacental mosaicism on cell-free DNA testing: a review of a common biological phenomenon. Ultrasound Obstet Gynecol 2016;48:415-423.

Gregg AR, Skotko BG, Benkendorf JL, et al. Noninvasive prenatal screening for fetal aneuploidy, 2016 update: a position statement of the American College of Medical Genetics and Genomics. Genet Med 2016;18:1056-65.

Dhamankar R, DiNonno W, Martin KA, Demko ZP, Gomez-Lobo V. Fetal Sex Results of Noninvasive Prenatal Testing and Differences With Ultrasonography. Obstet Gynecol 2020;135:1198-1206.

Smet ME, Scott FP, McLennan AC. Discordant fetal sex on NIPT and ultrasound. Prenat Diagn 2020;40:1353-1365.

Wang Y, Chen Y, Tian F, et al. Maternal mosaicism is a significant contributor to discordant sex chromosomal aneuploidies associated with noninvasive prenatal testing. Clin Chem 2014;60:251-9.

Yao H, Zhang L, Zhang H, et al. Noninvasive prenatal genetic testing for fetal aneuploidy detects maternal trisomy X. Prenat Diagn 2012;32:1114-6.

Zhang B, Zhou Q, Chen Y, et al. High false-positive noninvasive prenatal screening results for sex chromosome abnormalities: Are maternal factors the culprit? Prenat Diagn 2020;40:463-9.

Russell LM, Strike P, Browne CE, Jacobs PA. X chromosome loss and aging. Cytogenet Genome Res 2007;116:181-5.

Martin KA, Samango-Sprouse CA, Kantor V, et al. Detection of maternal X chromosome abnormalities using single nucleotide polymorphism-based noninvasive prenatal testing. Am J Obstet Gynecol MFM 2020;2:100152.

Sund KL, Khattar D, Boomer T, et al. Confirmatory testing illustrates additional risks for structural sex chromosome abnormalities in fetuses with a non-invasive prenatal screen positive for monosomy X. Am J Med Genet C Semin Med Genet 2020;184:294-301.

Délot EC, Vilain EJ. Nonsyndromic 46,XX Testicular Disorders of Sex Development. In: Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH, Gripp KW, Mirzaa GM, Amemiya A, editors. GeneReviews® Seattle (WA): University of Washington, Seattle; 1993-2022.